Avidity Partners Management LP
Top Portfolio Positions
52 positions ·
$526,034,692 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
2,104,184 | $176,583,121 | 33.57% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
1,288,948 | $87,236,000 | 16.58% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
760,424 | $37,298,797 | 7.09% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
13,301,075 | $34,848,815 | 6.62% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
6,049,999 | $25,228,495 | 4.80% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
1,400,708 | $19,679,947 | 3.74% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
400,000 | $15,680,000 | 2.98% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
450,100 | $13,557,012 | 2.58% | |
| RGEN |
Repligen Corp
Healthcare
|
77,800 | $9,166,396 | 1.74% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
70,000 | $8,725,500 | 1.66% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CGON
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $87,236,000 | 1,288,948 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $61,146,462 | 1,472,699 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $64,484,211 | 1,600,899 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,998,492 | 1,499,942 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,023,269 | 980,942 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,484,904 | 1,097,800 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $62,480,880 | 1,656,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $40,921,823 | 1,296,225 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $63,864,183 | 1,454,765 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||